- Home
- MNPR vs QIPT Comparison
MNPR vs QIPT Comparison
Compare MNPR & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- QIPT
- Stock Information
- Founded
- MNPR 2014
- QIPT 1993
- Country
- MNPR United States
- QIPT United States
- Employees
- MNPR N/A
- QIPT N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- QIPT
- Sector
- MNPR Health Care
- QIPT
- Exchange
- MNPR Nasdaq
- QIPT Nasdaq
- Market Cap
- MNPR 113.5M
- QIPT 129.3M
- IPO Year
- MNPR 2019
- QIPT N/A
- Fundamental
- Price
- MNPR $28.54
- QIPT $3.02
- Analyst Decision
- MNPR Strong Buy
- QIPT Strong Buy
- Analyst Count
- MNPR 4
- QIPT 3
- Target Price
- MNPR $38.50
- QIPT $7.67
- AVG Volume (30 Days)
- MNPR 59.4K
- QIPT 298.2K
- Earning Date
- MNPR 11-08-2024
- QIPT 02-12-2025
- Dividend Yield
- MNPR N/A
- QIPT N/A
- EPS Growth
- MNPR N/A
- QIPT N/A
- EPS
- MNPR N/A
- QIPT N/A
- Revenue
- MNPR N/A
- QIPT $245,915,000.00
- Revenue This Year
- MNPR N/A
- QIPT $7.34
- Revenue Next Year
- MNPR N/A
- QIPT $6.20
- P/E Ratio
- MNPR N/A
- QIPT N/A
- Revenue Growth
- MNPR N/A
- QIPT 16.17
- 52 Week Low
- MNPR $1.55
- QIPT $2.30
- 52 Week High
- MNPR $38.50
- QIPT $4.99
- Technical
- Relative Strength Index (RSI)
- MNPR 60.16
- QIPT 57.05
- Support Level
- MNPR $24.00
- QIPT $2.85
- Resistance Level
- MNPR $26.52
- QIPT $3.13
- Average True Range (ATR)
- MNPR 2.42
- QIPT 0.19
- MACD
- MNPR 0.32
- QIPT 0.01
- Stochastic Oscillator
- MNPR 68.85
- QIPT 77.95
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.